The serum metabolic disorder and the gut microbiota dysbiosis caused by SIRT2 deficiency is a critical driving force for diet-induced NAFLD, characterized by hepatic synthetic dysfunction, glycolipid metabolism disorders, insulin resistance, oxidative stress injury, liver lipid accumulation, inflammation, and liver fibrosis. The gene discussed is SIRT2; the disease is metabolic disease.